A 52-year-old man with major depressive disorder has been on… | MyMerci
Medical EmergenciesPA
Question
A 52-year-old man with major depressive disorder has been on venlafaxine 75 mg PO twice daily for 6 weeks. The dose was increased to 150 mg PO twice daily 4 weeks ago. He now reports persistent headache and tinnitus. Blood pressure measured today is 156/96 mmHg (baseline 124/78). Which action should the nurse take?
1Notify the prescriber about the new dose-related blood pressure rise, monitor BP, and review for additional pressor agents.✓ Correct answer
2Continue venlafaxine and increase the dose further because the depression may not be fully treated.
3Instruct the patient to stop venlafaxine immediately at home until the headache resolves.
4Tell the patient to reduce caffeine and recheck the blood pressure at his next routine visit in 3 months.
Explanation
Venlafaxine causes a dose-dependent rise in blood pressure, especially at doses above 150 mg/day, due to its noradrenergic activity. Headache, tinnitus, and a measurable rise from baseline indicate a real medication effect, not just lifestyle. The nurse should promptly notify the prescriber so dose, BP monitoring frequency, and other pressor exposures (NSAIDs, decongestants, stimulants) can be reviewed. Increasing the dose worsens hypertension. Deferring the visit ignores a documented adverse effect. Abrupt self-discontinuation risks severe SNRI withdrawal (dizziness, electric-shock sensations, flu-like symptoms).
In-depth explanation
SNRIs need a baseline BP and rechecks at every dose change — venlafaxine is the SNRI most likely to elevate BP; duloxetine has milder BP effects but still warrants monitoring.
Clinical scenario
Scenario A 52-year-old man with MDD started venlafaxine 6 weeks ago, currently on 150 mg PO twice daily for 4 weeks. He reports daily headache and tinnitus. BP 156/96 mmHg, HR 88, regular; baseline BP 124/78. No fever, no chest pain. Home meds: venlafaxine 150 mg BID, atorvastatin 20 mg, multivitamin. No NSAIDs, decongestants, or stimulants on review.
SNRI discontinuation — Abrupt SNRI cessation, especially venlafaxine due to short half-life, causes dizziness, vertigo, brain zaps, flu-like symptoms, anxiety, GI upset within 24-48 hours. Tapering over 2-4 weeks or longer is required; severe cases may need a fluoxetine bridge.
Venlafaxine BP monitoring — Baseline BP and serial monitoring after each dose increase, particularly above 150 mg/day. Sustained BP elevation may require dose reduction, switch to duloxetine, or addition of antihypertensive therapy.